Bockstal V, Shukarev G, McLean C, Goldstein N, et al. First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study. PLoS One 2022;17:e0274906.
PMID: 36197845